Media & Outreach
Interviews:
- Dr. Despina Siolas was recently featured in GI Oncology Now to discuss the vital role of mentorship, resilience, and collaboration in translational cancer research. She emphasized the importance of guiding young scientists, cultivating perseverance, and fostering an environment where ideas and encouragement are freely exchanged.
- Read the full interview: “Dr. Siolas: The Value of Mentorship and Resilience in GI Oncology Research,” here.
- Dr. Despina Siolas was recently featured in Women’s Health magazine in an expert round-up titled “Cancer Doctors Reveal the 12 Symptoms They Would Never Ignore—Beyond the Expected Ones.” In the interview, Dr. Siolas offers her clinical insight on subtle warning signs that deserve attention and discusses the importance of early detection.
- Read the full interview: "Cancer Doctors Reveal The 12 Symptoms They Would Never Ignore. Beyond the expected ones," here.
Features:
- Dr. Despina Siolas was recently featured in an in-depth article titled “A personalized approach to treating pancreatic cancer.” She shares how tailored treatment plans and emerging innovations are helping improve outcomes for patients facing this challenging diagnosis.
- Read the full feature: "A personalized approach to treating pancreatic cancer," here or visit Weill Cornell's website.
- Dr. Despina Siolas is honored to be featured in “Meet the Five Medical Minds Behind Project Purple’s Multi-Disciplinary Research Committee.” The article spotlights her contributions to cutting-edge pancreatic cancer research and her dedication to improving outcomes through teamwork and innovation.
- Read the full feature: "Meet The Five Medical Minds Behind Project Purple's Multi-Disciplinary Research Committee," here.
Clinical Trials
Cornell Cancer Clinical Trials:
Members of the Meyer Cancer Center lead and participate in a wide spectrum of clinical trials, including investigator-initiated, cooperative group, and pharmaceutical company-sponsored trials that incorporate the latest targeted agents and technological advances.
Find the list of clinical trials here.
Our Research Partners and Supporters
The Parker Institute for Cancer Immunotherapy
The Parker Institute for Cancer Immunotherapy works to accelerate the development of breakthorugh immune therapies in the fight against cancer, and break down infrastructure barriers that may slow down cancer research progress.
Cancer Research & Treatment Fund, Inc. (CR&T)
In 1968, Richard T. Silver, MD, a prominent oncologist, founded the Cancer Research & Treatment Fund (CR&T) with the belief that investing in blood cancer research would lead to important breakthroughs, as well as a better understanding of the biology and treatment of all forms of cancer. While the focus of the organization is the myeloproliferative neoplasms (MPNs), over the course of its 55-year history, CR&T has awarded more than $17 million in grants to research that has contributed to major advances in the fight against cancer.
National Pancreas Foundation
The National Pancreas Foundation provides hope for those suffering from pancreatitis and pancreatic cancer through funding cutting edge research, advocating for new and better therapies, and providing support and education for patients, caregivers, and health care professionals.
Pancreatic Cancer Action Network (PanCAN)
The Pancreatic Cancer Action Network is a United States-based 501 charity that funds research, provides patient/caregiver support, conducts community outreach and advocates for increased federal research funding for those affected by pancreatic cancer. PanCAN’s vision is to create a world in which all patients with pancreatic cancer will thrive.
